Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Blind Dose-Ranging Study in Subjects With Neurogenic Orthostatic Hypotension to Evaluate the Effect of CST-3056 on Symptoms and Signs of Orthostatic Hypotension

NCT07089043 is registered in ClinicalTrials.gov with CuraSen Therapeutics, Inc. as lead sponsor.

NCT NCT07089043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07089043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Blind Dose-Ranging Study in Subjects With Neurogenic Orthostatic Hypotension to Evaluate the Effect of CST-3056 on Symptoms and Signs of Orthostatic Hypotension
Lead sponsor
CuraSen Therapeutics, Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 12, 2025
Completion date
October 31, 2026
Enrollment
12 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

neurogenic orthostatic hypotension